Finance

Lists
Why is MOREPENLAB down 5.00%?
Dive Deeper
MOREPENLAB:NSE
Morepen Laboratories Ltd
₹102.31
-5.00%
(-5.38) 1D
Nov 3, 3:30:02 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for MOREPENLAB...
Open
₹102.31
High
₹102.31
Low
₹102.31
Mkt. cap
56.06B
Avg. vol.
11.61M
Volume
1.11M
Dividend
0.20%
Quarterly dividend
₹0.05
Ex-dividend date
Sep 18, 2026
P/E ratio
29.79
52-wk high
₹150.70
52-wk low
₹33.05
EPS
₹3.43
Shares outstanding
449.79M
No. of employees
2K
Open
₹102.31
High
₹102.31
Low
₹102.31
Mkt. cap
56.06B
Avg. vol.
11.61M
Volume
1.11M
Dividend
0.20%
Quarterly dividend
₹0.05
Ex-dividend date
Sep 18, 2026
P/E ratio
29.79
52-wk high
₹150.70
52-wk low
₹33.05
EPS
₹3.43
Shares outstanding
449.79M
No. of employees
2K
News stories
From web sources and news partners
About Morepen Laboratories Ltd
CEO-
Employees1.92K
Founded1984
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
4.84B
4.85B
5.70B
7.47B
Cost of goods sold
3.08B
2.92B
3.32B
4.02B
Cost of revenue
3.08B
2.92B
3.32B
4.02B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
872.10M
-168.89M
1.21B
1.66B
Operating expense
1.40B
1.74B
1.64B
2.31B
Total operating expenses
4.48B
4.66B
4.96B
6.33B
Operating income
359.34M
187.00M
741.85M
1.13B
Other non operating income
38.06M
-114.95M
51.83M
86.85M
EBT including unusual items
354.21M
232.88M
745.27M
1.17B
EBT excluding unusual items
354.21M
232.88M
745.27M
1.17B
Income tax expense
79.26M
75.87M
181.82M
276.49M
Effective tax rate
22.38%
32.58%
24.40%
23.72%
Other operating expenses
423.21M
1.85B
346.79M
555.09M
Net income
275.09M
157.45M
563.99M
888.87M
Net profit margin
5.68%
3.25%
9.89%
11.91%
Earnings per share
-
-
-
-
Interest and investment income
-
16.94M
-
-
Interest expense
-43.19M
-35.37M
-48.41M
-51.92M
Net interest expenses
-43.19M
-18.44M
-48.41M
-51.92M
Depreciation and amortization charges
103.82M
57.47M
83.49M
100.70M
EBITDA
401.52M
239.21M
832.94M
1.22B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps